Covalon Technologies Ltd. (COV) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.022x

Based on the latest financial reports, Covalon Technologies Ltd. (COV) has a cash flow conversion efficiency ratio of -0.022x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-667.21K ≈ $-482.65K USD) by net assets (CA$30.73 Million ≈ $22.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Covalon Technologies Ltd. - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Covalon Technologies Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Covalon Technologies Ltd. (COV) total liabilities for a breakdown of total debt and financial obligations.

Covalon Technologies Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Covalon Technologies Ltd. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Jinli Group Holdings Ltd
TW:8429
0.001x
Ascent Solar Technologies, Inc. Common Stock
NASDAQ:ASTI
-0.541x
Kafein Yazilim
IS:KFEIN
0.024x
Li Kang Biomedical Co Ltd
TWO:6242
-0.007x
Genoray Co. Ltd
KQ:122310
0.008x
Corem Property Group AB (publ)
ST:CORE-A
0.015x
Mentice AB
ST:MNTC
-0.086x
Caprice Resources Ltd
AU:CRS
-0.023x

Annual Cash Flow Conversion Efficiency for Covalon Technologies Ltd. (2005–2025)

The table below shows the annual cash flow conversion efficiency of Covalon Technologies Ltd. from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Covalon Technologies Ltd..

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-09-30 CA$30.73 Million
≈ $22.23 Million
CA$2.29 Million
≈ $1.66 Million
0.075x -41.00%
2024-09-30 CA$27.50 Million
≈ $19.90 Million
CA$3.47 Million
≈ $2.51 Million
0.126x +174.53%
2023-09-30 CA$18.79 Million
≈ $13.59 Million
CA$-3.18 Million
≈ $-2.30 Million
-0.169x +48.65%
2022-09-30 CA$24.23 Million
≈ $17.53 Million
CA$-7.99 Million
≈ $-5.78 Million
-0.330x -1872.06%
2021-09-30 CA$33.37 Million
≈ $24.14 Million
CA$621.37K
≈ $449.49K
0.019x +104.21%
2020-09-30 CA$9.11 Million
≈ $6.59 Million
CA$-4.03 Million
≈ $-2.91 Million
-0.442x -133.57%
2019-09-30 CA$14.93 Million
≈ $10.80 Million
CA$-2.83 Million
≈ $-2.04 Million
-0.189x -278.94%
2018-09-30 CA$13.12 Million
≈ $9.49 Million
CA$-655.47K
≈ $-474.16K
-0.050x -3061.17%
2017-09-30 CA$8.98 Million
≈ $6.50 Million
CA$15.15K
≈ $10.96K
0.002x +100.63%
2016-09-30 CA$3.81 Million
≈ $2.75 Million
CA$-1.03 Million
≈ $-742.05K
-0.269x +43.16%
2015-09-30 CA$4.79 Million
≈ $3.46 Million
CA$-2.27 Million
≈ $-1.64 Million
-0.474x -184.43%
2014-09-30 CA$5.53 Million
≈ $4.00 Million
CA$3.10 Million
≈ $2.24 Million
0.561x +211.29%
2013-09-30 CA$2.95 Million
≈ $2.13 Million
CA$-1.49 Million
≈ $-1.07 Million
-0.504x +50.18%
2012-09-30 CA$3.23 Million
≈ $2.34 Million
CA$-3.27 Million
≈ $-2.37 Million
-1.012x -113.61%
2011-09-30 CA$7.02 Million
≈ $5.07 Million
CA$-3.32 Million
≈ $-2.40 Million
-0.474x -6063.75%
2010-09-30 CA$7.57 Million
≈ $5.48 Million
CA$-58.20K
≈ $-42.10K
-0.008x +98.20%
2009-09-30 CA$10.94 Million
≈ $7.91 Million
CA$-4.67 Million
≈ $-3.38 Million
-0.427x -131.81%
2008-09-30 CA$15.02 Million
≈ $10.86 Million
CA$-2.76 Million
≈ $-2.00 Million
-0.184x -2114.69%
2007-09-30 CA$17.59 Million
≈ $12.73 Million
CA$-146.21K
≈ $-105.77K
-0.008x +97.04%
2006-09-30 CA$8.27 Million
≈ $5.98 Million
CA$-2.32 Million
≈ $-1.68 Million
-0.281x -13.16%
2005-09-30 CA$3.79 Million
≈ $2.74 Million
CA$-941.80K
≈ $-681.28K
-0.248x --

About Covalon Technologies Ltd.

V:COV Canada Medical Instruments & Supplies
Market Cap
$38.48 Million
CA$53.19 Million CAD
Market Cap Rank
#22821 Global
#832 in Canada
Share Price
CA$1.94
Change (1 day)
+2.65%
52-Week Range
CA$1.56 - CA$2.88
All Time High
CA$9.18
About

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company's platform technologies comprises collagen matrix platform that is used to manufacture a family of products to… Read more